A detailed history of Klingman & Associates, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Klingman & Associates, LLC holds 15,101 shares of JNJ stock, worth $2.42 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
15,101
Previous 15,679 3.69%
Holding current value
$2.42 Million
Previous $2.48 Million 11.01%
% of portfolio
0.15%
Previous 0.17%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$144.38 - $157.78 $83,451 - $91,196
-578 Reduced 3.69%
15,101 $2.21 Million
Q1 2024

May 01, 2024

SELL
$155.22 - $162.74 $23,127 - $24,248
-149 Reduced 0.94%
15,679 $2.48 Million
Q4 2023

Jan 29, 2024

SELL
$145.6 - $158.88 $4,513 - $4,925
-31 Reduced 0.2%
15,828 $2.48 Million
Q3 2023

Oct 30, 2023

SELL
$155.75 - $174.48 $43,921 - $49,203
-282 Reduced 1.75%
15,859 $2.47 Million
Q2 2023

Jul 31, 2023

SELL
$154.35 - $166.11 $177,502 - $191,026
-1,150 Reduced 6.65%
16,141 $2.67 Million
Q1 2023

May 03, 2023

SELL
$151.05 - $180.26 $33,835 - $40,378
-224 Reduced 1.28%
17,291 $2.68 Million
Q4 2022

Feb 03, 2023

BUY
$160.2 - $179.79 $40,690 - $45,666
254 Added 1.47%
17,515 $3.09 Million
Q3 2022

Oct 28, 2022

SELL
$161.33 - $179.52 $57,433 - $63,909
-356 Reduced 2.02%
17,261 $2.82 Million
Q2 2022

Jul 27, 2022

SELL
$168.19 - $186.01 $24,219 - $26,785
-144 Reduced 0.81%
17,617 $3.13 Million
Q1 2022

May 06, 2022

BUY
$158.14 - $179.59 $745,788 - $846,946
4,716 Added 36.15%
17,761 $3.15 Million
Q4 2021

Jan 31, 2022

BUY
$155.93 - $173.01 $23,389 - $25,951
150 Added 1.16%
13,045 $2.23 Million
Q3 2021

Nov 01, 2021

BUY
$161.5 - $179.47 $20,995 - $23,331
130 Added 1.02%
12,895 $2.08 Million
Q2 2021

Jul 27, 2021

SELL
$159.48 - $171.07 $243,525 - $261,223
-1,527 Reduced 10.68%
12,765 $2.1 Million
Q1 2021

Apr 29, 2021

BUY
$153.07 - $170.48 $199,603 - $222,305
1,304 Added 10.04%
14,292 $2.35 Million
Q4 2020

Feb 09, 2021

BUY
$137.11 - $157.38 $370,197 - $424,926
2,700 Added 26.24%
12,988 $2.04 Million
Q3 2020

Nov 03, 2020

BUY
$140.38 - $153.83 $157,927 - $173,058
1,125 Added 12.28%
10,288 $1.53 Million
Q2 2020

Aug 04, 2020

BUY
$128.81 - $155.51 $38,643 - $46,653
300 Added 3.38%
9,163 $1.29 Million
Q1 2020

Apr 29, 2020

BUY
$111.14 - $153.99 $89,356 - $123,807
804 Added 9.98%
8,863 $1.16 Million
Q4 2019

Jan 29, 2020

BUY
$127.5 - $146.44 $3,315 - $3,807
26 Added 0.32%
8,059 $1.18 Million
Q3 2019

Oct 22, 2019

SELL
$126.95 - $142.14 $4,316 - $4,832
-34 Reduced 0.42%
8,033 $1.04 Million
Q2 2019

Sep 27, 2019

BUY
$131.15 - $144.24 $1.06 Million - $1.16 Million
8,067 New
8,067 $1.12 Million
Q2 2019

Jul 24, 2019

SELL
$131.15 - $144.24 $1.05 Million - $1.16 Million
-8,033 Closed
0 $0
Q1 2019

May 03, 2019

BUY
$125.72 - $139.79 $12,572 - $13,979
100 Added 1.26%
8,033 $1.12 Million
Q2 2018

Aug 02, 2018

SELL
$119.4 - $131.76 $10,029 - $11,067
-84 Reduced 1.05%
7,933 $963,000
Q1 2018

Apr 25, 2018

SELL
$125.1 - $148.14 $989,916 - $1.17 Million
-7,913 Reduced 49.67%
8,017 $1.03 Million
Q4 2017

Feb 02, 2018

SELL
$131.22 - $143.62 $1.41 Million - $1.55 Million
-10,777 Reduced 40.35%
15,930 $2.23 Million
Q3 2017

Oct 24, 2017

BUY
$129.47 - $135.38 $3.46 Million - $3.62 Million
26,707
26,707 $3.47 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $419B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Klingman & Associates, LLC Portfolio

Follow Klingman & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingman & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klingman & Associates, LLC with notifications on news.